Renal pathological analysis using galactose-deficient IgA1-specific monoclonal antibody is a strong tool for differentiation of primary IgA nephropathy from secondary IgA nephropathy

zu Verbundenen Objekten

Standort
Deutsche Nationalbibliothek Frankfurt am Main
ISSN
2192-4449
Umfang
Online-Ressource
Sprache
Englisch
Anmerkungen
online resource.

Erschienen in
Renal pathological analysis using galactose-deficient IgA1-specific monoclonal antibody is a strong tool for differentiation of primary IgA nephropathy from secondary IgA nephropathy ; day:16 ; month:7 ; year:2020 ; pages:1-6
CEN Case Reports ; (16.7.2020), 1-6

Urheber
Lee, Mingfeng
Suzuki, Hitoshi
Kato, Rina
Fukao, Yusuke
Nakayama, Maiko
Kano, Toshiki
Makita, Yuko
Suzuki, Yusuke
Beteiligte Personen und Organisationen
SpringerLink (Online service)

DOI
10.1007/s13730-020-00508-3
URN
urn:nbn:de:101:1-2020091222350701007803
Rechteinformation
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
Letzte Aktualisierung
14.08.2025, 10:50 MESZ

Datenpartner

Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Original beim Datenpartner anzeigen

Beteiligte

  • Lee, Mingfeng
  • Suzuki, Hitoshi
  • Kato, Rina
  • Fukao, Yusuke
  • Nakayama, Maiko
  • Kano, Toshiki
  • Makita, Yuko
  • Suzuki, Yusuke
  • SpringerLink (Online service)

Ähnliche Objekte (12)

IgA nephropathy today : 10 tables

Konferenzschrift | Kongress

IgA nephropathy today : 10 tables

Current treatment of IgA nephropathy

Current treatment of IgA nephropathy

Complement activation in IgA nephropathy

Complement activation in IgA nephropathy

IgA Nephropathy: A Chinese Perspective

IgA Nephropathy: A Chinese Perspective

Current treatment of IgA nephropathy

Current treatment of IgA nephropathy

Clinical Significance of Galactose-Deficient IgA1 by KM55 in Patients with IgA Nephropathy

Clinical Significance of Galactose-Deficient IgA1 by KM55 in Patients with IgA Nephropathy

Leukemia Inhibitory Factor Signaling Enhances Production of Galactose-Deficient IgA1 in IgA Nephropathy

Leukemia Inhibitory Factor Signaling Enhances Production of Galactose-Deficient IgA1 in IgA Nephropathy

Clinical Significance of Galactose-Deficient IgA1 by KM55 in Patients with IgA Nephropathy

Clinical Significance of Galactose-Deficient IgA1 by KM55 in Patients with IgA Nephropathy

IgA Nephropathy Secondary to Ipilimumab Use

IgA Nephropathy Secondary to Ipilimumab Use

IgA nephropathy: a perspective for 2021

IgA nephropathy: a perspective for 2021

IgA nephropathy: a perspective for 2021

IgA nephropathy: a perspective for 2021

IgA nephropathy to proliferative glomerulonephritis with monoclonal IgAκ deposits: a pattern switch

IgA nephropathy to proliferative glomerulonephritis with monoclonal IgAκ deposits: a pattern switch

Verbundene Objekte